Organisation paid for research Program year 2024 Source: CMS Open Payments

Advanced Pharma Research Inc

Neither a doctor nor a teaching hospital

Research payments

$45,189

4 payments

Through program year 2024, Advanced Pharma Research Inc is reported as receiving $45,189 in research payments, across 4 payments.

By program year

2 rows
Year Kind Amount Payments
2024 Research $4,830 2
2023 Research $40,360 2

Breakdown

Who paid Research payments · program years 2023–2024
  1. AstraZeneca UK Limited $26,189 3 payments
  2. Genentech, Inc. $19,000 1 payment
Studies the money was for Research payments · program years 2023–2024
  1. A Phase 2, Randomised, Double-Blind, Placebo and Active Comparator-Controlled Study to Assess Efficacy and Safety of Multiple Dose Levels of AZD5718 Given Orally Once Daily for Twelve Weeks in Adults with Moderate-to-Severe Uncontrolled Asthma $26,189 3 payments
  2. Roche Cancer Screening Collection Study $19,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record